Bevacizumab in High-Risk Corneal Transplantation A Pilot Multicenter Prospective Randomized Control Trial

Overview of attention for article published in Ophthalmology, March 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter: 10 X users

Readers on

mendeley: 30 Mendeley

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 35,491 followers.

@aaojournal and a team led by @hmseye @masseyeandear found no difference at 1 year but post Hoc found decreased transplant failure long term (2/2). #MedTwitter #ophthalmology #sciencetwitter Read more ⬇️ https://t.co/siRAreHdCe

RT @AAOjournal: Bevacizumab in High-Risk Corneal Transplantation: a Pilot Multi-Center Prospective Randomized Control Trial https://t.co/BX…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 6 additional X posts.